GNH USA

Europe — EMA

Grandise

Grandise contains granisetron hydrochloride, an oral 5‑HT3 antagonist used to prevent chemotherapy‑ and postoperative‑induced nausea and vomiting.

Granisetron Hydrochloride

Request sourcing

1
Pack/s

What is Granisetron Hydrochloride?

Grandise is an oral medication that contains the active ingredient granisetron hydrochloride. It is supplied in a prescription‑only format and marketed in the European Union. Granisetron belongs to the 5‑HT3 receptor antagonist class and is used as an antiemetic to help control nausea and vomiting. The product is formulated for systemic absorption after swallowing and does not contain additional active strengths listed or dosage variations.

What is Granisetron Hydrochloride used for?

Grandise is indicated for the prevention of nausea and vomiting associated with specific medical procedures.

- Prevention of chemotherapy‑induced nausea and vomiting (CINV). - Prevention of postoperative nausea and vomiting (PONV). - Use as part of a multimodal antiemetic regimen in high‑risk patients. - May be employed when other 5‑HT3 antagonists are not suitable. - Suitable for adult patients undergoing moderately or highly emetogenic chemotherapy.

What are the side effects of Granisetron Hydrochloride?

The safety profile of granisetron hydrochloride includes both frequent, mild reactions and rare, more serious events.

Common: - Headache. - Constipation. - Fatigue. - Dizziness. - Diarrhea.

Serious: - Severe allergic reaction (anaphylaxis). - Cardiac arrhythmia. - QT interval prolongation. - Serotonin syndrome when combined with serotonergic agents.

What precautions apply to Granisetron Hydrochloride?

Before prescribing Grandise, clinicians should evaluate several safety considerations to minimize risk.

- Assess cardiac history, especially QT prolongation risk. - Review concomitant medications that affect heart rhythm. - Use caution in patients with hepatic impairment. - Monitor for signs of hypersensitivity during initial doses. - Adjust dose or avoid use in severe renal dysfunction. - Consider pregnancy and breastfeeding status, although data are limited.

What does Granisetron Hydrochloride interact with?

Granisetron may interact with other drugs, requiring attention to avoid adverse effects.

Avoid: - Other 5‑HT3 antagonists (duplicate therapy). - Drugs known to prolong QT interval (e.g., certain antiarrhythmics, macrolide antibiotics).

Use with caution: - Serotonergic agents such as SSRIs, SNRIs, or tramadol. - Antifungal azoles (e.g., ketoconazole). - Certain antipsychotics (e.g., haloperidol).

Frequently asked questions

What is the mechanism of action of granisetron hydrochloride in Grandise?+
Granisetron hydrochloride selectively blocks serotonin 5‑HT3 receptors in the central nervous system and gastrointestinal tract, interrupting the signaling pathway that triggers nausea and vomiting.
Can Grandise be used for nausea caused by radiation therapy?+
Granisetron is primarily approved for chemotherapy‑induced and postoperative nausea and vomiting; use for radiation‑induced nausea should be considered off‑label and discussed with a healthcare professional.
Is Grandise available over the counter in the European Union?+
No, Grandise is a prescription‑only medication (Rx) in the EU and must be prescribed by a qualified healthcare provider.
How should Grandise be taken to achieve optimal antiemetic effect?+
Grandise is taken orally, usually 30 minutes before the start of chemotherapy or surgery, as directed by the prescribing clinician.
What are common side effects patients may notice after taking Grandise?+
Common side effects include headache, constipation, fatigue, dizziness, and mild diarrhea.
Are there any serious adverse reactions associated with Grandise?+
Serious reactions, though rare, can include severe allergic responses, cardiac arrhythmias, QT interval prolongation, and serotonin syndrome when combined with serotonergic drugs.
Should patients with a history of heart rhythm problems avoid Grandise?+
Patients with known QT prolongation or other cardiac rhythm disorders should be evaluated carefully, and alternative antiemetics may be preferred.
Can Grandise be taken together with other antiemetic medications?+
Granisetron can be part of a multimodal regimen, but duplicate therapy with another 5‑HT3 antagonist should be avoided.
What monitoring is recommended for patients on Grandise?+
Clinicians may monitor ECG for QT changes, assess liver function in hepatic impairment, and watch for signs of hypersensitivity during the initial treatment period.
Is Grandise safe for use during pregnancy or breastfeeding?+
Safety data in pregnancy and lactation are limited; the medication should only be used if the potential benefit justifies the potential risk, after consulting a healthcare professional.
How does renal impairment affect the use of Grandise?+
Severe renal dysfunction may require dose adjustment or alternative therapy, as granisetron is primarily eliminated unchanged by the kidneys.
What should a patient do if they miss a dose of Grandise?+
If a dose is missed, the patient should take it as soon as they remember unless the next scheduled dose is near; they should not double the dose and should follow the prescriber's instructions.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Granisetron Hydrochloride
Route
Oral Use
Manufacturer
Lanova Farmaceutici S.R.L.
Origin
EU

Related products